We are live on ! Find out more
ED

Exane Derivatives Portfolio holdings

AUM $174M
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
+5.26%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
AUM
$721M
AUM Growth
Cap. Flow
+$656M
Cap. Flow %
90.9%
Top 10 Hldgs %
24.78%
Holding
517
New
516
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 13.44%
2 Healthcare 12.89%
3 Financials 9.48%
4 Industrials 6.55%
5 Materials 5.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INDY icon
501
iShares S&P India Nifty 50 Index Fund
INDY
$545M
$120 ﹤0.01%
+4
New +$122
HRL icon
502
Hormel Foods
HRL
$13.9B
$104 ﹤0.01%
+4
New +$105
HSBC icon
503
CALL
HSBC
HSBC
$355B
$100 ﹤0.01%
+23
New +$981
ALTO icon
504
Alto Ingredients
ALTO
$360M
$72 ﹤0.01%
+7
New +$85
SU icon
505
Suncor Energy
SU
$77.7B
$64 ﹤0.01%
+2
New +$66
PAAS icon
506
Pan American Silver
PAAS
$18.6B
$55 ﹤0.01%
+6
New +$60
SCTY
507
DELISTED
SolarCity Corporation
SCTY
$53 ﹤0.01%
+1
New +$54
AVNS icon
508
Avanos Medical
AVNS
$1.17B
$38 ﹤0.01%
+1
New +$39
AG icon
509
First Majestic Silver
AG
$8.05B
$25 ﹤0.01%
+5
New +$28
BLMN icon
510
Bloomin' Brands
BLMN
$680M
$25 ﹤0.01%
+1
New +$21
CNP icon
511
CenterPoint Energy
CNP
$29.1B
$23 ﹤0.01%
+1
New +$24
VOD icon
512
CALL
Vodafone
VOD
$34.9B
$20 ﹤0.01%
+5
New +$169
SUNE
513
DELISTED
SUNEDISON, INC COM
SUNE
$20 ﹤0.01%
+1
New +$19
BHP icon
514
CALL
BHP
BHP
$213B
$10 ﹤0.01%
+6
New +$277
KGC icon
515
Kinross Gold
KGC
$28.5B
$8 ﹤0.01%
+3
New +$8
RAS
516
DELISTED
RAIT Financial Trust
RAS
$8 ﹤0.01%
+1
New +$7

Similar funds

Exane Derivatives's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Exane Derivatives, which disclosed 517 positions worth $721M. Its ten largest holdings account for 25% of the portfolio.

Its largest position is UBS Group: 1,731,016 shares worth $29.9M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, followed by Healthcare and Financials.

  • Exane Derivatives's largest Q4 2014 buy was UBS Group: 1,731,016 shares worth $29.9M.
  • Exane Derivatives's ten largest holdings make up 25% of its $721M portfolio in Q4 2014.
  • Exane Derivatives disclosed 517 positions in Q4 2014, its first 13F filing on record.

Based on Exane Derivatives's 13F filing for Q4 2014, filed 11 Feb 2015.